Development of a manufacturing process for a novel TB vaccine

Ended Project Grant Awarded Last action

Award ID
R01AI098911
Recipient
Awarding agency
Obligated
$6,505,841

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Place of performance
Maryland, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$0
Amendment Development of a manufacturing process for a novel TB vaccine - description (provided by applicant): tuberculosis (TB) is a significant global health concern… -$0
Amendment $27,455
Amendment $27,455
Amendment -$27,455
Amendment -$1,197,737
Amendment $27,455
Amendment -$27,455
Amendment $1,553,871
Amendment $1,553,871
Amendment $1,553,871
Amendment $1,460,639
Amendment $442,771
Original award $1,111,100
Show all 14

Quick answers

Who received award R01AI098911?

R01AI098911 was awarded to Emergent Product Development Gaithersburg Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 20, 2012.

How much is award R01AI098911 worth?

$6,505,841 has been obligated on R01AI098911.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award